1
|
Rodríguez-Poncelas A, Franch-Nadal J, Coll-de Tuero G, Mata-Cases M, Alonso-Fernández M, Mur-Marti T, Ruiz A, Giraldez-García C, Regidor E. High levels of fasting glucose and glycosylated hemoglobin values are associated with hyperfiltration in a Spanish prediabetes cohort. The PREDAPS Study. PLoS One 2019; 14:e0222848. [PMID: 31536578 PMCID: PMC6752878 DOI: 10.1371/journal.pone.0222848] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2019] [Accepted: 09/08/2019] [Indexed: 11/19/2022] Open
Abstract
AIM This study aimed to investigate whether different levels of fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) in prediabetes are associated with hyperfiltration. METHODS A prospective cohort of 2,022 individuals aged 30-74 years took part in the PREDAPS Study. One cohort of 1,184 participants with prediabetes and another cohort of 838 participants with normal FPG and normal HbA1c were followed for 5 years. Hyperfiltration was defined as an estimated glomerular filtration rate (eGFR) above the age- and gender-specific 95th percentile for healthy control participants, while hypofiltration was defined as an eGFR below the 5th percentile. The prevalence of hyperfiltration was compared for different levels of prediabetes: level 1 of prediabetes: FPG <100 mg/dL plus HbA1c 5.7-6.0% or FPG 100-109 mg/dL plus HbA1c < 5.7%; level 2 of prediabetes: FPG <100 mg/dL plus HbA1c 6.1-6.4% or FPG 100-109 mg/dL plus HbA1c 5.7-6.0% or FPG 110-125 mg/dL plus HbA1c <5.7% and level 3 of prediabetes: FPG 100-109 mg/dL plus HbA1c 6.1-6.4% or FPG 110-125 mg/dL plus HbA1c 5.7-6.4%. RESULTS The participants with hyperfiltration were significantly younger, had a higher percentage of active smokers, and lower levels of hemoglobin and less use of ACEIs or ARBs. Only level 3 prediabetes based on FPG 100-109 mg/dL plus HbA1c 6.1-6.4% or FPG 110-125 mg/dL plus HbA1c 5.7-6.4% had a significantly higher odds ratio (OR) of hyperfiltration (OR 1.69 (1.05-2.74); P < 0.001) compared with no prediabetes (FPG < 100 mg/dL and HbA1c < 5.7%) after adjustment for different factors. The odds ratios for different levels of HbA1c alone in prediabetes increased progressively, but not significantly. CONCLUSIONS Level 3 of prediabetes based on FPG 100-109 mg/dL plus HbA1c 6.1-6.4% or FPG 110-125 mg/dL plus HbA1c 5.7-6.4% had a significantly higher OR of hyperfiltration compared with participants without prediabetes.
Collapse
Affiliation(s)
- Antonio Rodríguez-Poncelas
- METHARISC Group, USR Girona, IDIAP Gol i Gorina, Girona, Spain
- Grup de Recerca Epidemiològica en Diabetis des de l´Atenció Primària (DAP_CAT) Jordi Gol, Barcelona, Spain
- RedGDPS Foundation, Madrid, Spain
| | - Josep Franch-Nadal
- RedGDPS Foundation, Madrid, Spain
- USR Barcelona ciutat–IDIAP Jordi Gol, Barcelona, Spain
- CIBER Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain
- Departament de Medicina, Universitat de Barcelona, Barcelona, Spain
| | - Gabriel Coll-de Tuero
- METHARISC Group, USR Girona, IDIAP Gol i Gorina, Girona, Spain
- Departamento de Ciencias Médicas, Universitat de Girona, Girona, Spain
| | - Manel Mata-Cases
- Grup de Recerca Epidemiològica en Diabetis des de l´Atenció Primària (DAP_CAT) Jordi Gol, Barcelona, Spain
- RedGDPS Foundation, Madrid, Spain
- USR Barcelona ciutat–IDIAP Jordi Gol, Barcelona, Spain
- CIBER Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain
| | - Margarita Alonso-Fernández
- RedGDPS Foundation, Madrid, Spain
- Centro de Salud La Ería, Asturias, Spain
- Departamento de Medicina Preventiva y Salud Publica, Universidad de Oviedo, Asturias, Spain
| | - Teresa Mur-Marti
- RedGDPS Foundation, Madrid, Spain
- Mutua Terrassa, Barcelona, Spain
| | - Antonio Ruiz
- RedGDPS Foundation, Madrid, Spain
- Centro de Salud Universitario Pinto, Madrid, Spain
| | | | - Enrique Regidor
- RedGDPS Foundation, Madrid, Spain
- Departamento de Salud Pública y Materno-Infantil, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain
- CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain
| |
Collapse
|